Effects of Purified Newly Developed Botulinum Neurotoxin Type A in Rat Prostate

Yasuhiro Nishiyama, Teruhiko Yokoyama, Kazuhito Tomizawa, Kikuo Okamura, Yumiko Yamamoto, Hideki Matsui, Keiji Oguma, Atsushi Nagai, Hiromi Kumon

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objectives: To investigate the efficacy of a newly purified neurotoxin (NTX) in male rat prostates. Several reports have suggested that intraprostatic injection of botulinum toxin type A has demonstrated efficacy against symptomatic benign prostatic hyperplasia. NTXs associate with nontoxic components and form large complexes designated "progenitor toxins." In general, progenitor toxins are used, because they are easily obtained and are more stable than NTXs. However, they have side effects for some patients in whom anti-progenitor toxins, including anti-NTX antibodies, are produced after several injections. We purified NTXs without their nontoxic components using a simple procedure. Methods: Adult male Sprague-Dawley rats were injected with 5 U of NTX or saline into their prostates, which were harvested and weighed after 1 or 4 weeks. The effects of the NTX on the prostate were histologically and immunohistochemically studied using hematoxylin-eosin, synaptophysin, and terminal deoxynucleotidyl-mediated deoxyuridine triphosphate nick end labeling staining. Results: In the NTX-treated rats, the prostate weight was reduced and atrophy and diffuse apoptosis were observed. Moreover, synaptophysin-positive cells in the epithelium were decreased after NTX injection. Conclusions: Intraprostatic NTX injection induces prostate apoptosis and atrophic change in the rat prostate. These results suggest that NTX injection might be a promising material for treatment of patients with benign prostatic hyperplasia.

Original languageEnglish
Pages (from-to)436-439
Number of pages4
JournalUrology
Volume74
Issue number2
DOIs
Publication statusPublished - Aug 2009

Fingerprint

Neurotoxins
Prostate
Injections
Synaptophysin
Prostatic Hyperplasia
Apoptosis
Type A Botulinum Toxins
Hematoxylin
Eosine Yellowish-(YS)
Atrophy
Sprague Dawley Rats
Anti-Idiotypic Antibodies
Epithelium
Staining and Labeling
Weights and Measures

ASJC Scopus subject areas

  • Urology

Cite this

Effects of Purified Newly Developed Botulinum Neurotoxin Type A in Rat Prostate. / Nishiyama, Yasuhiro; Yokoyama, Teruhiko; Tomizawa, Kazuhito; Okamura, Kikuo; Yamamoto, Yumiko; Matsui, Hideki; Oguma, Keiji; Nagai, Atsushi; Kumon, Hiromi.

In: Urology, Vol. 74, No. 2, 08.2009, p. 436-439.

Research output: Contribution to journalArticle

Nishiyama, Yasuhiro ; Yokoyama, Teruhiko ; Tomizawa, Kazuhito ; Okamura, Kikuo ; Yamamoto, Yumiko ; Matsui, Hideki ; Oguma, Keiji ; Nagai, Atsushi ; Kumon, Hiromi. / Effects of Purified Newly Developed Botulinum Neurotoxin Type A in Rat Prostate. In: Urology. 2009 ; Vol. 74, No. 2. pp. 436-439.
@article{ab2292be8c1e4ca980e1aee517cf5485,
title = "Effects of Purified Newly Developed Botulinum Neurotoxin Type A in Rat Prostate",
abstract = "Objectives: To investigate the efficacy of a newly purified neurotoxin (NTX) in male rat prostates. Several reports have suggested that intraprostatic injection of botulinum toxin type A has demonstrated efficacy against symptomatic benign prostatic hyperplasia. NTXs associate with nontoxic components and form large complexes designated {"}progenitor toxins.{"} In general, progenitor toxins are used, because they are easily obtained and are more stable than NTXs. However, they have side effects for some patients in whom anti-progenitor toxins, including anti-NTX antibodies, are produced after several injections. We purified NTXs without their nontoxic components using a simple procedure. Methods: Adult male Sprague-Dawley rats were injected with 5 U of NTX or saline into their prostates, which were harvested and weighed after 1 or 4 weeks. The effects of the NTX on the prostate were histologically and immunohistochemically studied using hematoxylin-eosin, synaptophysin, and terminal deoxynucleotidyl-mediated deoxyuridine triphosphate nick end labeling staining. Results: In the NTX-treated rats, the prostate weight was reduced and atrophy and diffuse apoptosis were observed. Moreover, synaptophysin-positive cells in the epithelium were decreased after NTX injection. Conclusions: Intraprostatic NTX injection induces prostate apoptosis and atrophic change in the rat prostate. These results suggest that NTX injection might be a promising material for treatment of patients with benign prostatic hyperplasia.",
author = "Yasuhiro Nishiyama and Teruhiko Yokoyama and Kazuhito Tomizawa and Kikuo Okamura and Yumiko Yamamoto and Hideki Matsui and Keiji Oguma and Atsushi Nagai and Hiromi Kumon",
year = "2009",
month = "8",
doi = "10.1016/j.urology.2009.01.047",
language = "English",
volume = "74",
pages = "436--439",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Effects of Purified Newly Developed Botulinum Neurotoxin Type A in Rat Prostate

AU - Nishiyama, Yasuhiro

AU - Yokoyama, Teruhiko

AU - Tomizawa, Kazuhito

AU - Okamura, Kikuo

AU - Yamamoto, Yumiko

AU - Matsui, Hideki

AU - Oguma, Keiji

AU - Nagai, Atsushi

AU - Kumon, Hiromi

PY - 2009/8

Y1 - 2009/8

N2 - Objectives: To investigate the efficacy of a newly purified neurotoxin (NTX) in male rat prostates. Several reports have suggested that intraprostatic injection of botulinum toxin type A has demonstrated efficacy against symptomatic benign prostatic hyperplasia. NTXs associate with nontoxic components and form large complexes designated "progenitor toxins." In general, progenitor toxins are used, because they are easily obtained and are more stable than NTXs. However, they have side effects for some patients in whom anti-progenitor toxins, including anti-NTX antibodies, are produced after several injections. We purified NTXs without their nontoxic components using a simple procedure. Methods: Adult male Sprague-Dawley rats were injected with 5 U of NTX or saline into their prostates, which were harvested and weighed after 1 or 4 weeks. The effects of the NTX on the prostate were histologically and immunohistochemically studied using hematoxylin-eosin, synaptophysin, and terminal deoxynucleotidyl-mediated deoxyuridine triphosphate nick end labeling staining. Results: In the NTX-treated rats, the prostate weight was reduced and atrophy and diffuse apoptosis were observed. Moreover, synaptophysin-positive cells in the epithelium were decreased after NTX injection. Conclusions: Intraprostatic NTX injection induces prostate apoptosis and atrophic change in the rat prostate. These results suggest that NTX injection might be a promising material for treatment of patients with benign prostatic hyperplasia.

AB - Objectives: To investigate the efficacy of a newly purified neurotoxin (NTX) in male rat prostates. Several reports have suggested that intraprostatic injection of botulinum toxin type A has demonstrated efficacy against symptomatic benign prostatic hyperplasia. NTXs associate with nontoxic components and form large complexes designated "progenitor toxins." In general, progenitor toxins are used, because they are easily obtained and are more stable than NTXs. However, they have side effects for some patients in whom anti-progenitor toxins, including anti-NTX antibodies, are produced after several injections. We purified NTXs without their nontoxic components using a simple procedure. Methods: Adult male Sprague-Dawley rats were injected with 5 U of NTX or saline into their prostates, which were harvested and weighed after 1 or 4 weeks. The effects of the NTX on the prostate were histologically and immunohistochemically studied using hematoxylin-eosin, synaptophysin, and terminal deoxynucleotidyl-mediated deoxyuridine triphosphate nick end labeling staining. Results: In the NTX-treated rats, the prostate weight was reduced and atrophy and diffuse apoptosis were observed. Moreover, synaptophysin-positive cells in the epithelium were decreased after NTX injection. Conclusions: Intraprostatic NTX injection induces prostate apoptosis and atrophic change in the rat prostate. These results suggest that NTX injection might be a promising material for treatment of patients with benign prostatic hyperplasia.

UR - http://www.scopus.com/inward/record.url?scp=67651122991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651122991&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2009.01.047

DO - 10.1016/j.urology.2009.01.047

M3 - Article

VL - 74

SP - 436

EP - 439

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -